Page 53 - Pharma

Government launches equity fund for biotechnology

The fund, be operated by Biotechnology Industry Research Assistance Council (BIRAC), is aimed at accelerating the growth of entrepreneurs in the field of biotechnology

Solve financing woes to boost pharma exports to Africa: Ashok Agarwala

African countries offer huge export market for Indian bulk drug exporters. However, to give a fillip, solution needs to be found for solving export financing problems

Gujarat Alkalies to use IICT technology to produce hydrazine hydrate

The company plans to set up a plant, which will have a capacity to produce 8000 TPA of 80% hydrazine hydrate based on IICT technology that uses hydrogen peroxide route

Eye-Q Super Specialty raises Rs 60 cr from IFC, Helion and Nexus

The hospital chain will use the funding to expand access of high quality and affordable eye care treatments in India

Dr Reddy's establishes formulation development laboratory in Hyderabad

With this expansion, the laboratory will form a Center of Excellence for fully integrated API and formulation development services

Glenmark receives approval for asthma drug in Russia

The company has already launched the drug, which is a generic version of Seretide, in a host of emerging markets like Mexico and Philippines

DCGI gives nod to Natco & Hetero to produce Gilead's hepatitis C drug

Both the companies had entered into non-exclusive licensing agreement with Gilead Sciences to manufacture and sell generic versions of its chronic hepatitis C medicine, sofosbuvir

Lupin completes acquisition of South Africa's Pharma Dynamics

In September 2008, Lupin had acquired a strategic 60% equity stake in Pharma Dynamics - the Cape Town headquartered company

Suven Life receives 2 patents for CNS drug in US & New Zealand

With these new patents, Suven has a total of 20 granted patents in the US and 23 patents in New Zealand

US FDA finds Granules India's Gagillapur facility okay

The US drug regulator had inspected Gagillapur facility (near Hyderabad) last week and the inspection concluded with no observations, says the company

US FDA grants approvals to Jubilant for hypertension and anti-allergic drugs

The company has received approvals for irbesartan and cetirizine (chewable) tablets

Glenmark receives US FDA approval for oral contraceptive Ashlyna

Ashlyna is an extended-cycle oral contraceptive tablets and a generic equivalent of Seasonique, which had recorded sales of $159 mn in 2014

Govt plans to set up drug price monitoring cells in India

The proposal has a component for setting up consumer awareness, price monitoring and resource units at the states/union territories

Dr Datsons Labs inks supply pact with Yemen's Al-Mugdh Pharma for anti-malarial drugs

The company is revamping its factory in Pune to cater to the overseas market and it estimates to receive orders worth Rs 80 crore from Yemen

Jubilant Life receives US FDA approval for asthma drug montelukast

The total market size for montelukast tablets - a generic version of Merck's Singulair chewable tablets - is estimated to be $83 million per annum in the US

Experts welcome inclusion of NCDs in draft National Health Policy

The promotion of alternate therapies like ayurveda, yoga and naturopathy can also result in providing cost-effective management of non-communicable diseases (NCDs)

Natco inks licensing agreement with US-based Gilead for hepatitis C drugs

The drugs include sofosbuvir, ledipasvir/sofosbuvir and the investigational NS5A inhibitor GS-5816

Government to set up AIM to nurture innovation culture

Atal Innovation Mission (AIM) will involve academics, entrepreneurs and researchers to foster a culture of innovation, R&D and scientific research in India

Lupin receives USFDA nod for bimatoprost ophthalmic solution

Bimatoprost ophthalmic solution is the generic equivalent of Allergan Inc's Lumigan solution

Valeant acquires Salix Pharmaceuticals for $14.5 bn

Acquisition of Salix, a leader in the growing US gastrointestinal market, is expected to create a strong platform for Valeant's growth and business development